Video

Dr. Singal on the Importance of Early Diagnosis in HCC

Amit G. Singal, MD, discusses the importance of early diagnosis for patients with hepatocellular carcinoma.

Amit G. Singal, MD, associate professor, UT Southwestern Medical Center, discusses the importance of early diagnosis for patients with hepatocellular carcinoma (HCC).

There have been several advances with locoregional and systemic therapies in HCC, says Singal. However, early identification and diagnosis remains a key component in the management of these patients.

Patients with early-stage HCC should be referred to a transplant center to determine whether or not they are eligible for surgical resection or liver transplant, explains Singal.

Though checkpoint inhibitors have improved survival for patients, they are associated with a risk of transplant rejection, says Singal. As such, transplant eligibility should be determined before beginning systemic therapy, concludes Singal.

Related Videos
J. Bradley Elder, MD
Rimas V. Lukas, MD
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD